title: Open access to large scale datasets is needed to translate knowledge of cancer heterogeneity into better patient outcomes.
abstract: In this guest editorial, Andrew Beck discusses the importance of open access to big data for translating knowledge of cancer heterogeneity into better outcomes for cancer patients.
authors.affiliation: Cancer Research Institute, Beth Israel Deaconess Cancer Center, Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, United States of America.
authors.forename: Andrew H
authors.initials: AH
authors.lastname: Beck
mesh_terms: D022126:Access to Information; D016208:Databases, Factual; D066264:Datasets as Topic; D014644:Genetic Variation; D006301:Health Services Needs and Demand; D006801:Humans; D058990:Molecular Targeted Therapy; D009369:Neoplasms / Q000235:genetics / Q000628:therapy*; D014175:Translating; D057170:Translational Research, Biomedical